CD2 and arthritic joint disease: Rather, the local microenvironment, particularly CD200+ fibroblasts, acted as gatekeepers of arthritis, engaging the checkpoint receptor CD200R1 on migrating CD2+MHC-II+CCR2+ myeloid precursors.